Skip to main content

Highlights

  1. 1
    Nature biotechnology · 2023
    PMID: 36593397PMCID: PMC10272089DOIFirst author178 citations

Publications

22 publications

Funding

7 grants

Active

3 grants
  • Co-I
    Dynamics of Immune Response in Irradiated Rectal Cancer
    National Cancer Institute · 2022–2027
    U54CA274291-01
  • PI
    Extending the survival of HR+ breast cancer patients receiving CDK4/6 inhibitors by targeting IL17-producing gamma delta T cells
    U.S. Department of Defense · 2022–2027
    W81XWH-22-1-0506
  • PI
    Harnessing Innate Immunity and Radiotherapy for Next-Generation Immuno-Oncology in Metastatic Breast Cancer
    METAvivor Research and Support, Inc. · 2025–2027
    MRS 243992-02
Completed grants (4)
  • KP
    Genetic Reprogramming of the Solid Tumor Immune Microenvironment
    Emerson Collective Cancer Research Fund · 2021–2024 · via University of Pennsylvania
    UP 215255-02
  • KP
    Deciphering differentiation hierarchies, heritability and plasticity in gliomas via single-cell multi-omics.
    Sontag Foundation, Inc. · 2020–2024
    SFI 203261-01
  • KP
    Shapeshifters in Cancers – Defining Epidrivers of Cancer Evolution in Response to Targeted Therapy
    Pershing Square Sohn Cancer Research Alliance · 2018–2021
    No publications yet
    PSSCR 194743-01
  • KP
    Cupid-seq – high throughput transcriptomic spatial mapping of immune-tumor interactions in the micro-environment
    American Association for Cancer Research · 2018–2020
    SU2C-AACR-PS-20

News mentions

Mentoring

1 mentee